WASHINGTON — Foreign governments and corporations could profit from American academic institutions’ failure to safeguard taxpayer-funded biomedical research, according to a set of new reports from a federal watchdog.

The reports, issued by the Department of Health and Human Services inspector general, show that 54% of research institutions funded by the National Institutes of Health — some 1,013 universities and academic centers — failed to publish financial conflict-of-interest policies online. In 2018, according to the report, the NIH conducted just three audits to determine grantee institutions’ own efforts to safeguard their research — down from 28 in 2012.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I don’t know if you or HHS know that 50-75% of research has been reported to be unreproducible. If this is true, the problem is like stealing “fake news.” The system has never been good at supporting replication studies, so why not let other countries do it? With Open Science, they might even improve the ideas for the common good! The U.S. should shed its bias for English-only journals and blindspots by learning what others are doing abroad.

  • US pharmas are doing the same all the time, by profiteering from taxpayer-funded biomedical research, without paying their due royalties.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy